Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioLine Rx

2.65
-0.2900-9.86%
Post-market: 2.790.1399+5.28%18:07 EDT
Volume:55.82K
Turnover:152.96K
Market Cap:9.86M
PE:-0.57
High:2.90
Open:2.84
Low:2.58
Close:2.94
Loading ...

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
21 Feb

BLRX: Aphexda Transition Progressing

Zacks Small Cap Research
·
19 Feb

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
18 Feb

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
14 Feb

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
05 Feb

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
31 Jan

BioLineRx trading halted, news pending

TIPRANKS
·
30 Jan

BioLineRx Changes Ratio of ADSs to Ordinary Shares

MT Newswires Live
·
18 Jan

S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings

Benzinga
·
18 Jan

BioLineRx changes ratio of ADRs to ordinary shares

TIPRANKS
·
17 Jan

BioLineRx Announces $10 Million Registered Direct Offering

PR Newswire
·
06 Jan

Press Release: Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors

Dow Jones
·
10 Dec 2024

BLRX: Ayrmid Assumes Commercialization Efforts

Zacks Small Cap Research
·
04 Dec 2024

JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
27 Nov 2024

BioLine Rx Ltd (BLRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts

GuruFocus.com
·
26 Nov 2024

BioLine RX Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Nov 2024

BioLineRx price target lowered to $9 from $21 at H.C. Wainwright

TIPRANKS
·
26 Nov 2024

BioLineRx Secures Key Deals to Boost Shareholder Value

TIPRANKS
·
25 Nov 2024

BioLineRx GAAP EPS of $0.00 beats by $0.07, revenue of $4.94M misses by $0.35M

seekingalpha
·
25 Nov 2024

BioLine Rx Q3 2024 GAAP EPS $(0.00) Beats $(0.05) Estimate, Sales $4.94M Miss $5.29M Estimate

Benzinga
·
25 Nov 2024